Question 1

Does Morgan Stanley own KLRS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 72,326 shares of KLRS (Kalaris Therapeutics), worth $294,367.

Question 2

How many shares of KLRS does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 72,326 shares of KLRS (Kalaris Therapeutics).

Question 3

What is Morgan Stanley's KLRS position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's KLRS position is worth $294,367.

Question 4

Is Morgan Stanley buying or selling KLRS?

Accepted Answer

In Q2 2026, Morgan Stanley increased its KLRS position by 33,982 shares (+88.6%).

Question 5

When did Morgan Stanley first buy KLRS?

Accepted Answer

Morgan Stanley already held KLRS in its Q1 2025 13F, the earliest on record, and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	72,326	+88.6%	$294,367	0.0%	$4.07	25
2026-Q1	Increased	38,344	+37.2%	$221,245	0.0%	$9.42	20
2025-Q4	Increased	27,948	+12.2%	$235,881	0.0%	$8.38	18
2025-Q3	Increased	24,918	+1168.7%	$144,026	0.0%	$6.35	25
2025-Q2	Increased	1,964	+51.5%	$5,244	0.0%	$2.62	14
2025-Q1	New	1,296	-	$10,406	0.0%	$8.60	26

KLRS6 quarters

KLRS
6 quarters